VIRAX BIOLABS GROUP LTD (VRAX) Stock Earnings & Estimates
USA - NASDAQ:VRAX - KYG9495L1251 - Common Stock
0.6133 USD
-0.01 (-2.26%)
0.6186 USD
+0.01 (+0.86%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 8.6K | 156.4K 1,718.60% | 6.3K -95.97% | 13.762M 218,344.44% | 4.08M -70.35% | 7.14M 75.00% | 11.22M 57.14% | 17.34M 54.55% | 23.46M 35.29% | 26.52M 13.04% | |
| EBITDA YoY % growth | N/A | -6.003M -2.67% | -5.82M 3.06% | 612.5K 110.52% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -5.733M -231.38% | -6.106M -6.51% | -6.163M -0.93% | 612.5K 109.94% | N/A | N/A | N/A | N/A | N/A | N/A | |
| Operating Margin | -66,660.47% | -3,904.16% | -97,823.81% | 4.45% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A -5.56% | N/A 68.42% | 0.04 166.67% | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 68.42% | -0.61 | % |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 1.4K -98.25% | % | ||
| Q2 2025 Q2Q % growth | 5K -93.46% | % | ||
| Q4 2024 Q2Q % growth | 79.9K 2,753.57% | % | ||
| Q4 2022 Q2Q % growth | -100.00% | % | ||
| Q2 2022 Q2Q % growth | -100.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | 0% |
| Revenue | N/A | N/A | 0% | 0% |